According to Radiology Business, the Tampa-based Moffitt Cancer Center announced the launch of a new radiopharma program backed by a $600 million investment. The initiative officially started on August 25.
Reports indicate that the program is aimed at accelerating radiopharmaceutical research, development, and clinical translation at the Florida cancer center.